Brief: Cg Oncology Provides Updated Timeline For Pivot-006 Phase 3 Topline Data In Intermediate-Risk Nmibc
09/01/2026 14:06
Jan 9 (Reuters) - CG Oncology Inc CGON.O: CG ONCOLOGY PROVIDES UPDATED TIMELINE FOR PIVOT-006 PHASE 3 TOPLINE DATA IN INTERMEDIATE-RISK NMIBC CG ONCOLOGY INC - EXPECTS PHASE 3 PIVOT-006 DATA IN 1H 2026 Source text: ID:nGNX9Y2PmR Further company coverage: CGON.O ((Reuters.Briefs@thomsonreuters.com;))